- Home
- ORC vs ELVN Comparison
ORC vs ELVN Comparison
Compare ORC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORC | ELVN |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ORC | ELVN |
|---|---|---|
| Price | $7.21 | $15.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $7.50 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 6.0M | 796.1K |
| Earning Date | 01-29-2026 | 11-12-2025 |
| Dividend Yield | ★ 20.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $80,187,000.00 | N/A |
| Revenue This Year | $90.64 | N/A |
| Revenue Next Year | $78.88 | N/A |
| P/E Ratio | $12.55 | ★ N/A |
| Revenue Growth | ★ 5.93 | N/A |
| 52 Week Low | $5.69 | $13.30 |
| 52 Week High | $9.01 | $25.37 |
Technical Indicators
Market Signals| Indicator | ORC | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 35.13 |
| Support Level | $7.28 | $15.88 |
| Resistance Level | $7.40 | $18.05 |
| Average True Range (ATR) | 0.12 | 1.13 |
| MACD | -0.00 | -0.16 |
| Stochastic Oscillator | 27.72 | 9.68 |
Price Performance
Historical ComparisonAbout ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.